• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首次出现艾滋病定义疾病的HIV阳性患者:特征与生存情况。

HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.

作者信息

Poznansky M C, Coker R, Skinner C, Hill A, Bailey S, Whitaker L, Renton A, Weber J

机构信息

Department of Genitourinary Medicine and Communicable Diseases, St Mary's Hospital Medical School, London.

出版信息

BMJ. 1995 Jul 15;311(6998):156-8. doi: 10.1136/bmj.311.6998.156.

DOI:10.1136/bmj.311.6998.156
PMID:7613426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2550220/
Abstract

OBJECTIVES

To study the presentation and survival of patients who present with their first diagnosis of being HIV positive at the same time as their AIDS defining illness.

DESIGN

Retrospective study of patients presenting with AIDS between 1991 and 1993.

SETTING

Department of genitourinary medicine, St Mary's Hospital, London.

MAIN OUTCOME MEASURES

AIDS defining illness at presentation and survival after diagnosis of AIDS.

RESULTS

Between January 1991 and December 1993, 97 out of 436 patients (22%) presented with their first AIDS defining illness coincident with their first positive result of an HIV test (group B). The remaining 339 patients (78%) had tested positive for HIV-1 infection within the previous eight years and had consequently been followed up in clinics before developing their first AIDS defining illness (group A). The two groups of patients did not differ in age and sex distribution, risk factors for HIV-1 infection, nationality, country of origin, or haematological variables determined at the time of the AIDS defining illness. However, the defining illnesses differed between the two groups. Illnesses associated with severe immunodeficiency (the wasting syndrome, cryptosporidiosis, and cytomegalovirus infection) were seen almost exclusively in group A whereas extrapulmonary tuberculosis and Pneumocystis carinii pneumonia were more common in group B. The survival of patients in group B after the onset of AIDS was significantly longer than that of patients in group A as determined by Kaplan-Meier log rank analysis (P = 0.0026).

CONCLUSIONS

Subjects who are HIV positive and present late are a challenge to the control of the spread of HIV infection because they progress from asymptomatic HIV infection to AIDS without receiving health care. The finding that presentation with an AIDS defining illness coincident with a positive result in an HIV test did not have a detrimental effect on survival gives insights into the effects of medical intervention on disease progression after a diagnosis of AIDS.

摘要

目的

研究首次诊断为HIV阳性同时伴有艾滋病定义疾病的患者的临床表现及生存情况。

设计

对1991年至1993年间出现艾滋病症状的患者进行回顾性研究。

地点

伦敦圣玛丽医院泌尿生殖医学科。

主要观察指标

就诊时的艾滋病定义疾病以及艾滋病诊断后的生存情况。

结果

在1991年1月至1993年12月期间,436例患者中有97例(22%)首次出现艾滋病定义疾病时HIV检测结果呈阳性(B组)。其余339例患者(78%)在过去8年内HIV-1感染检测呈阳性,因此在出现首次艾滋病定义疾病之前一直在诊所接受随访(A组)。两组患者在年龄、性别分布、HIV-1感染的危险因素、国籍、原籍国或艾滋病定义疾病发生时所测定的血液学变量方面无差异。然而,两组的定义疾病有所不同。与严重免疫缺陷相关的疾病(消瘦综合征、隐孢子虫病和巨细胞病毒感染)几乎仅见于A组,而肺外结核和卡氏肺孢子虫肺炎在B组更为常见。通过Kaplan-Meier对数秩分析确定,B组患者在艾滋病发病后的生存期明显长于A组患者(P = 0.0026)。

结论

HIV阳性且就诊较晚的患者对控制HIV感染传播构成挑战,因为他们在未接受医疗保健的情况下从无症状HIV感染进展为艾滋病。首次出现艾滋病定义疾病时HIV检测结果呈阳性对生存没有不利影响这一发现,为了解艾滋病诊断后医疗干预对疾病进展的影响提供了见解。

相似文献

1
HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.首次出现艾滋病定义疾病的HIV阳性患者:特征与生存情况。
BMJ. 1995 Jul 15;311(6998):156-8. doi: 10.1136/bmj.311.6998.156.
2
Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.1987 - 1998年伦敦一家诊所中艾滋病界定疾病的变化情况。
J Acquir Immune Defic Syndr. 1999 Aug 15;21(5):401-7.
3
The role of initial AIDS-defining illness in survival following AIDS.
AIDS. 1995 Jan;9(1):57-63. doi: 10.1097/00002030-199501000-00008.
4
Impact of pregnancy on maternal AIDS.妊娠对孕产妇艾滋病的影响。
J Reprod Med. 1997 Jul;42(7):429-34.
5
AIDS in Africans living in London.居住在伦敦的非洲人中的艾滋病情况。
Genitourin Med. 1995 Dec;71(6):358-62. doi: 10.1136/sti.71.6.358.
6
Disease progression and survival following specific AIDS-defining conditions: a retrospective cohort study of 2048 HIV-infected persons in London.
AIDS. 1998 Jun 18;12(9):1007-13. doi: 10.1097/00002030-199809000-00006.
7
Profile of opportunistic infections among HIV-1 infected people in Hong Kong.香港HIV-1感染者中的机会性感染概况。
Zhonghua Yi Xue Za Zhi (Taipei). 1995 Feb;55(2):127-36.
8
The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy.高效抗逆转录病毒治疗时代终末期艾滋病的临床特征。
AIDS Patient Care STDS. 2002 Feb;16(2):75-81. doi: 10.1089/10872910252806126.
9
[AIDS and injecting drug use: survival determinants in the highly active antiretroviral therapy era].[艾滋病与注射吸毒:高效抗逆转录病毒治疗时代的生存决定因素]
Epidemiol Prev. 2009 Jul-Oct;33(4-5):184-9.
10
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group.
Int J Epidemiol. 1997 Apr;26(2):400-7. doi: 10.1093/ije/26.2.400.

引用本文的文献

1
Sociobehavioral Risk Factors and Clinical Implications of Late Presentation Among People Living with HIV in the Brazilian Amazon Region.巴西亚马逊地区艾滋病毒感染者晚期出现的社会行为风险因素及其临床意义。
AIDS Behav. 2024 Oct;28(10):3404-3420. doi: 10.1007/s10461-024-04437-5. Epub 2024 Jul 11.
2
Interferon gamma release assays and the NICE 2011 guidelines on the diagnosis of latent tuberculosis.干扰素释放试验与 NICE 2011 年关于潜伏性结核诊断指南。
Clin Med (Lond). 2013 Aug;13(4):362-6. doi: 10.7861/clinmedicine.13-4-362.
3
'Slipping through the cracks': policy implications of delays in HIV treatment seeking.“错失治疗时机”:艾滋病治疗延迟带来的政策影响。
Glob Public Health. 2012;7(10):1095-108. doi: 10.1080/17441692.2012.701318. Epub 2012 Jul 19.
4
Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007.与布鲁塞尔和法国北部晚期 HIV 疾病就诊相关的因素:1997-2007 年。
BMC Infect Dis. 2011 Jan 12;11:11. doi: 10.1186/1471-2334-11-11.
5
Severity and outcomes of Pneumocystis pneumonia in patients newly diagnosed with HIV infection: an observational cohort study.新诊断的HIV感染患者肺孢子菌肺炎的严重程度及预后:一项观察性队列研究
Scand J Infect Dis. 2009;41(9):672-8. doi: 10.1080/00365540903051633.
6
Declining incidence of AIDS and increasing prevalence of AIDS presenters among AIDS patients in Italy.意大利艾滋病患者中艾滋病发病率下降,艾滋病患者报告人数增加。
Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):663-9. doi: 10.1007/s10096-003-1038-8. Epub 2003 Oct 21.
7
The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition.各种艾滋病流行的化学基础:消遣性药物、抗病毒化疗与营养不良。
J Biosci. 2003 Jun;28(4):383-412. doi: 10.1007/BF02705115.
8
Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.白细胞介素-8和生长调节致癌基因α介导卡波西肉瘤中的血管生成。
J Virol. 2002 Nov;76(22):11570-83. doi: 10.1128/jvi.76.22.11570-11583.2002.
9
Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells.由HIV-1感染的T细胞产生的炎性细胞因子诱导HHV-8裂解周期复制。
Am J Pathol. 2000 Jun;156(6):1961-71. doi: 10.1016/S0002-9440(10)65069-9.
10
Factors associated with the time elapsed between the initial detection of HIV-1 antibodies and a diagnosis of AIDS among patients followed in Lyons University Hospitals. CISIH Collaborators.里昂大学医院随访的患者中,与HIV-1抗体初次检测至艾滋病诊断之间所经过时间相关的因素。CISIH协作组。
Sex Transm Infect. 1999 Dec;75(6):389-91. doi: 10.1136/sti.75.6.389.

本文引用的文献

1
Factors associated with lack of awareness of HIV infection before diagnosis of AIDS.艾滋病诊断前与未意识到感染艾滋病毒相关的因素。
BMJ. 1993 Jul 3;307(6895):20-3. doi: 10.1136/bmj.307.6895.20.
2
Cost effectiveness analysis of early zidovudine treatment of HIV infected patients.齐多夫定早期治疗HIV感染患者的成本效益分析。
BMJ. 1993 Nov 20;307(6915):1322-5. doi: 10.1136/bmj.307.6915.1322.
3
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.齐多夫定用于无症状HIV感染者且CD4+细胞计数大于每立方毫米400个的人群。欧洲-澳大利亚协作组。
N Engl J Med. 1993 Jul 29;329(5):297-303. doi: 10.1056/NEJM199307293290501.
4
Survival prognosis of HIV-infected patients.HIV感染患者的生存预后。
J Acquir Immune Defic Syndr (1988). 1993 Jun;6(6):624-9.
5
The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.
JAMA. 1994 Aug 10;272(6):437-42.
6
Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City.获得性免疫缺陷综合征的生存情况。纽约市5833例病例的经验。
N Engl J Med. 1987 Nov 19;317(21):1297-302. doi: 10.1056/NEJM198711193172101.
7
Survival patterns of the first 500 patients with AIDS in San Francisco.旧金山首批500例艾滋病患者的生存模式。
J Infect Dis. 1988 May;157(5):1044-7. doi: 10.1093/infdis/157.5.1044.
8
Earlier diagnosis of human immunodeficiency virus (HIV) infection and more counseling.
Ann Intern Med. 1989 May 1;110(9):680-1. doi: 10.7326/0003-4819-110-9-680.
9
Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS.英国一家转诊中心艾滋病患者疾病模式的变化:艾滋病面貌的改变。
BMJ. 1991 Jan 26;302(6770):203-7. doi: 10.1136/bmj.302.6770.203.
10
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.齐多夫定与卡氏肺孢子虫肺炎预防对HIV-1感染进展至艾滋病的影响。多中心艾滋病队列研究。
Lancet. 1991 Aug 3;338(8762):265-9. doi: 10.1016/0140-6736(91)90414-k.